Faheema Siddiqui

Dr. Faheema Siddiqui


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2023 in Heliyon
Verified
Journal Article
Open access
LALaila Anwar
Laila Anwar
SASyed Abid Ali
Syed Abid Ali
SKSana Khan
Sana Khan
MUMir Muhammad Uzairullah
Mir Muhammad Uzairullah
NMNazish Mustafa
Nazish Mustafa
GAGhulam Abbas
Ghulam Abbas
Senescence is a natural phenomenon of growing old. It accelerates under certain conditions like diabetes mellitus resulting in early decline of bodily functions, which can be avoided by many claimed functional foods. The present study aims to investigate the anti-aging ability of Fenugreek seeds (Trigonellafoenum-graecum); a common ingredient of Indo-Pak cuisines. Briefly, the Fenugreek seeds extract (FgSE) in concentrationsof0.1, 0.5 and 1 mg/ml inhibited the formation of Advanced Glycation End products (AGEs) and fructosamine adducts in Bovine serum albumin (BSA)/fructose model in vitro. The BSA conformational analysis via Circular Dichorism and Congo red assays showed that it preserves secondary structure of BSA in aforementioned model. Although mechanistic studies revealed insignificant lysine blocking ability of Fenugreek by OPA assay, however carbonyl entrapping was found to be 24%, 34% and 42% at 0.1, 0.5 and 1 mg/ml, respectively. In vivo model of High Fructose diet (HFD) induced glycation, FgSE treatment in doses of 10, 25 & 50 mg/kg markedly improved Escape latency (p < 0.01) and preserved cognition in Morris Water Maze. Our data further exhibits significant decrease of CML (Nε-carboxymethyl lysine) levels in serum and hippocampus byFgSE treatment in comparison with HFD group. Therefore, we deduced that FgSE prevents glycation-induced memory decline via entrapping the reactive carbonyl intermediates, formed during production of AGEs. Hence, as a promising functional food it slows down the harmful process of glycation and aging associated morbidities.

1 November 2021 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
FSFaheema Siddiqui
Faheema Siddiqui
AFAhsana Dar Farooq
Ahsana Dar Farooq
MUMudassar
Mudassar
NKNurul Kabir
Nurul Kabir
NFNarjis Fatima
Narjis Fatima
SFShaheen Faizi
Shaheen Faizi


24 February 2022 in Medicinal Chemistry Research
Verified
Journal Article
Open access
PDF file
SHShazia Haider
Shazia Haider
ZSZafar Saied Saify
Zafar Saied Saify
NMNousheen Mushtaq
Nousheen Mushtaq
FSFaheema Siddiqui
Faheema Siddiqui
TRToqeer Ahmed Rao
Toqeer Ahmed Rao
NBNasreen Begum
Nasreen Begum
In the study of designing pharmacophore models for analgesic, a series of 4-[4–chloro-3- (trifluoromethyl)-phenyl]-4-piperidinol (TFMP) derivatives were synthesized and characterized by physical and spectral method (HR-EIMS, HR-FABMS, 1H-NMR, 13C-NMR, UV, and FT-IR). The analgesic action of the synthesized derivatives was estimated by means of Hot Plate Method. Most of the compounds displayed potent analgesic efficacy and an ultrashort to long duration of action. The results indicate that these compounds are useful as analgesics. In the presence of naloxone they displayed pain reliving effect. In conclusion, among active compounds 3 (188%), 5 (137%), 6 (162%), and 8 (107%) respectively, emerged as most effective analgesic and they depressed peripheral and centrally mediated pain by opioid independent systems.

7 August 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
ANAlmas Naeem
Almas Naeem
NJNoor Jahan
Noor Jahan
MKMoona Khan
Moona Khan
GAGhulam Abbas
Ghulam Abbas
FSFaheema Siddiqui
Faheema Siddiqui
WFWaqas Ahmed Farooqui
Waqas Ahmed Farooqui
Leflunomide is an isoxazole immunomodulating drug used to treat rheumatoid arthritis (RA). It is adopted as a metal-containing molecule to proceed with saturated salts of essential and detected metals; it amends the pharmacokinetic and pharmacodynamics activity of leflunomide to provide [M(Lef)4]X2-type complexes. Earlier it has been reported that after forming complexes with metals, leflunomide anti-arthritic activity was significantly altered in an acute arthritic model. In the present study, we evaluated the possible modification in anti-arthritic activities of leflunomide–metal complexes (Mg+2, Ca+2, Fe+2, Zn+2) with and without an anti-depressant drug, i.e., fluoxetine (10 mg/kg) in a chronic AIA model. Rats (n = 5) were administered with 0.1 mL of CFA into the right hind paw while treated groups received leflunomide and its metal complexes orally (3.2 mg/kg) for 24 days. On the final day of experiment, rats were sacrificed; a specific rat immunoassay ELISA kit was used to assess TNF-α in serum samples and read at 450 nm; a tissue sample of a paw was homogenized in a phosphate buffer using DCFH-DA dye for binding to assess ROS. A rat’s brain sample was homogenized and evaluated for tryptophan, serotonin (5-HT), and HIAA by RP-HPLC with EC detector. The overall TNF production was altered in treated rats. In addition, a decreased ROS was observed in all categories, except lef+Mg+2 group. Moreover, depletion in the brain indolamine levels were found in treated groups; an upraised level of these indolamines was observed when fluoxetine was added. It is concluded that metals affect leflunomide activity on complexation and simultaneous administration of fluoxetine cope up with the depression in arthritic-induced rats.

5 November 2023 in IBRO Neuroscience Reports
Verified
Journal Article
Open access
NJNoor Jahan
Noor Jahan
FAFarah Aslam
Farah Aslam
FSFaheema Siddiqui
Faheema Siddiqui
MAMehtab Alam
Mehtab Alam